Skip to content

Xencor XNCR Net margin

Net margin at other companies

Amgen logo
AmgenAMGN
21%+3.6pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
29.6%-2.3pp
Janux Therapeutics logo
Janux TherapeuticsJANX
-833.6%+0.9pp
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-181.7%-77.9pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-49.9%-22.6pp
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-4,612.1%

Other financials

Income statement

See full
Revenue$4.5M-86.2%
Operating income-$77.9M-80.3%
Net income-$128.9M-166%
EPS (diluted)-$1.71-159%

Balance sheet

See full
Cash & equivalents$14.2M-64.3%
Total debt$175.2M-21.2%
Total equity$515.6M-19.4%
Total assets$736.8M-18.6%

Cash flow

See full
Operating cash flow-$67.6M-317%
CapEx$610.0K-57.8%
Free cash flow-$68.2M-286%

Valuation

See full
Market cap$1.07B+76.3%
Enterprise value$1.23B+55.9%
P/S11×+6.2×

Profitability

See full
Operating margin-217.9%+425pp
FCF margin-194%+166pp

Returns & leverage

See full
Return on equity-29.8%-2.7pp
Debt / equity0.3×0.0×
Current ratio6.6×+0.7×

Where this comes from

Calculated from Xencor’s reported figures.

Based on trailing twelve months.

The official record: Xencor’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xencor's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xencor's net margin?
Xencor (XNCR) reported net margin of -177.1% in Q1 2026.
How has Xencor's net margin changed year-over-year?
Xencor's net margin decreased by 8.5% year-over-year, from -163.2% to -177.1%.
What is the long-term trend for Xencor's net margin?
Over 5 years (2020 to 2025), Xencor's net margin has grown at a 5.3% compound annual growth rate (CAGR), from -56.5% to -73.2%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.